Roche’s Virtual Event following Angiogenesis 2021
Agenda:
Welcome
Ophthalmology Strategy Update
Ophthalmology Pipeline Update
Faricimab in DME and nAMD – Phase III results
Q&A
Karl Mahler, Head of Investor Relations and Roche Group Planning
Atul Dandekar, Vice President and Global Franchise Head of Ophthalmology Product Strategy
Christopher Brittain, Vice President and Global Head of Ophthalmology Product Development
Nancy Holekamp, M.D., Retina Specialist and Clinical Investigator

Please register to access the replay*

*Privacy notice

Live Webinar Replay

Roche has hosted a virtual event on Tuesday, 16th February 2021.

Investors
Past IR Events
View more Events

Downloads

Related links